Literature DB >> 12524644

Chemoembolization for hepatic metastases.

Michael Gee1, Michael C Soulen.   

Abstract

Liver metastases are one of the most difficult therapeutic challenges in modern oncologic practice. Few systemic therapies are effective for solid tumors in the liver. Resection is possible in a minority of patients and usually not curative. Image-guided therapies such as chemoembolization offer substantial intensification of treatment by combining tumor ischemia, increased drug concentrations, prolonged dwell time, and reduced systemic toxicity. Although not a curative therapy, durable responses are seen in most adenocarcinomas, which may contribute to prolongation and preservation of quality of life by delaying liver failure in patients with liver-dominant disease. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Year:  2002        PMID: 12524644     DOI: 10.1053/tvir.2002.36422

Source DB:  PubMed          Journal:  Tech Vasc Interv Radiol        ISSN: 1557-9808


  3 in total

1.  Treating coronary vasospasm and tumor burden medically.

Authors:  James A York
Journal:  Tex Heart Inst J       Date:  2012

2.  Transarterial chemoembolization complicated by deteriorating hepatic function.

Authors:  Jim Gehl; Reed A Omary
Journal:  Semin Intervent Radiol       Date:  2011-06       Impact factor: 1.513

3.  Short-term effectiveness of radiochemoembolization for selected hepatic metastases with a combination protocol.

Authors:  Shahram Akhlaghpoor; Alireza Aziz-Ahari; Mahasti Amoui; Shahnaz Tolooee; Hossein Poorbeigi; Shahab Sheybani
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.